Key Points
New Delhi: After a string of adverse events in the last two years, Indias apex drug regulator will from 15 May onwards grant manufacturing licenses for drugs that are banned or unapproved in India but can be exported...
The latest directive reverses its 2018 order which waived the provision of procuring central NOC by pharmaceutical companies for exporting drugs, medical devices and cosmetics in a bid to ensure ease of doing business...
The new order is aimed at ensuring that the CDSCO has a database of all the drugs being supplied outside India, as currently we dont have a full list of medicines which are being exported from the country, a senior CDSCO official told ThePrint...
Udaya Bhaskar, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), an agency under the Union Ministry of Commerce and Industry, said that the new order would further streamline the process of drug exports from India...
As per figures shared by Pharmexcil, Indias exports of pharmaceuticals during 2022-23 was valued at $25.4 billion with a growth of almost 3.25 percent over the previous financial year..
